Identification |
Name: | 4-Hexenoic acid,6-[(2R,4R,5S)-2-(2-chlorophenyl)-4-(2-hydroxyphenyl)-1,3-dioxan-5-yl]-,(4Z)-rel- |
Synonyms: | 4-Hexenoicacid, 6-[2-(2-chlorophenyl)-4-(2-hydroxyphenyl)-1,3-dioxan-5-yl]-, [2a,4a,5a(Z)]-;ICI 191606;ICI 192605; |
CAS: | 117621-64-4 |
Molecular Formula: | C22H23ClO5 |
Molecular Weight: | 402.868 |
InChI: | InChI=1/C22H23ClO5/c23-18-11-6-4-9-16(18)22-27-14-15(8-2-1-3-13-20(25)26)21(28-22)17-10-5-7-12-19(17)24/h1-2,4-7,9-12,15,21-22,24H,3,8,13-14H2,(H,25,26)/b2-1-/t15-,21+,22+/m1/s1 |
Molecular Structure: |
|
Properties |
Density: | 1.262 g/cm3 |
Refractive index: | 1.583 |
Biological Activity: | Potent thromboxane A 2 receptor (TP receptor) antagonist. Competitively inhibits contractile responses to U46619 . |
Safety Data |
|
|